Tiveljung A, Borch K, Jonasson J, Mårdh S, Petersson F, Monstein H J
Division of Clinical Microbiology, Faculty of Health Sciences, University of Linköping, Sweden.
J Med Microbiol. 1998 Aug;47(8):695-704. doi: 10.1099/00222615-47-8-695.
The aim of the present study was to correlate molecular evidence of the presence of Helicobacter pylori in gastric biopsy samples, based on analysis of 16S rDNA, vacuolating toxin (vacA), urease A (ureA) and cagA genes, with the clinical, histological and serological findings in patients with H. pylori-associated gastritis. Fresh biopsy samples were collected from the gastric antrum and corpus of 22 asymptomatic volunteers with or without H. pylori-associated gastritis. Total DNA was extracted from the biopsy material and subjected to 16S rDNA PCR amplification, Southern blotting and 16S rDNA sequence analysis of the PCR products. The vacA, ureA and cagA genes were characterised by PCR amplification and Southern blot analysis. Based on partial 16S rDNA sequence analysis, DNA belonging to the genus Helicobacter was detected in gastric biopsy samples from 20 of 22 subjects, including seven of nine histologically and serologically normal controls. Six of 20 partial 16S rDNA sequences revealed variations within variable regions V3 and V4 that deviated from those of the H. pylori type strain ATCC 4350T and, therefore, possibly represented other species of Helicobacter. VacA genes identical with those of the type strain were found predominantly in the subjects with H. pylori gastritis, and all the patients except one were found to be cagA-positive. There was no evidence of false positive PCR reactions. In conclusion, the PCR-based molecular typing methods used here were apparently too sensitive when applied to the detection of H. pylori in human gastric tissues. The lack of quantitative analysis makes them inappropriate as clinical tools for the diagnosis of H. pylori-associated gastritis, despite the fact that they provide a qualitative and sensitive tool for the detection and characterisation of H. pylori in the gastrointestinal tract.
本研究的目的是基于对16S rDNA、空泡毒素(vacA)、脲酶A(ureA)和cagA基因的分析,将胃活检样本中幽门螺杆菌存在的分子证据与幽门螺杆菌相关性胃炎患者的临床、组织学和血清学结果相关联。从22名有无幽门螺杆菌相关性胃炎的无症状志愿者的胃窦和胃体采集新鲜活检样本。从活检材料中提取总DNA,并对其进行16S rDNA PCR扩增、Southern印迹分析以及PCR产物的16S rDNA序列分析。通过PCR扩增和Southern印迹分析对vacA、ureA和cagA基因进行鉴定。基于部分16S rDNA序列分析,在22名受试者中20人的胃活检样本中检测到属于幽门螺杆菌属的DNA,其中包括9名组织学和血清学正常对照中的7人。20个部分16S rDNA序列中的6个在可变区V3和V4内显示出与幽门螺杆菌标准菌株ATCC 4350T不同的变异,因此可能代表幽门螺杆菌的其他物种。与标准菌株相同的VacA基因主要在幽门螺杆菌胃炎患者中发现,除1名患者外,所有患者均为cagA阳性。没有PCR假阳性反应的证据。总之,这里使用的基于PCR的分子分型方法在应用于检测人胃组织中的幽门螺杆菌时显然过于敏感。尽管它们为胃肠道中幽门螺杆菌的检测和鉴定提供了定性且灵敏的工具,但缺乏定量分析使其不适用于作为诊断幽门螺杆菌相关性胃炎的临床工具。